Related Experiment Video
Updated: May 10, 2025

08:32
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
10.4K
Human cytomegalovirus infection induces L1 expression through UL38-dependent mTOR-KAP1 pathway
Sehong Park1,2,3, Jiseok Jeong1,2,3, Kwangseog Ahn1,2,3
1Center for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Plos One
|April 23, 2025
Summary
Human cytomegalovirus (HCMV) upregulates LINE-1 (L1) expression by inactivating the epigenetic repressor KAP1 via mTOR-mediated phosphorylation. This interaction facilitates HCMV DNA replication and viral spread.
Area of Science:
- Virology
- Epigenetics
- Molecular Biology
Background:
- Human cytomegalovirus (HCMV) and LINE-1 (L1) retrotransposons coexist within host cells.
- HCMV upregulates L1 expression to enhance its own DNA replication and life cycle.
- The mechanism of HCMV-mediated L1 upregulation was previously unknown.
Purpose of the Study:
- To elucidate the molecular mechanism by which HCMV increases L1 expression.
- To investigate the role of KRAB-associated protein 1 (KAP1) in HCMV-induced L1 upregulation.
- To identify viral factors regulating the mTOR-KAP1 pathway during HCMV infection.
Main Methods:
- Cell culture and HCMV infection models.
- Western blotting to detect KAP1 phosphorylation.
- Chromatin accessibility assays to assess L1 promoter activity.
- Treatment with mTOR inhibitors and analysis of HCMV mutants (UL38).
Main Results:
- HCMV infection phosphorylates KAP1 at S824, reducing its repressive function.
- This phosphorylation increases chromatin accessibility at the L1 promoter.
- mTOR kinase activation by HCMV drives KAP1 phosphorylation and L1 expression.
- HCMV UL38 protein is essential for activating the mTOR-KAP1 pathway and L1 upregulation.
Conclusions:
- HCMV infection functionally inactivates the epigenetic repressor KAP1 through mTOR-mediated phosphorylation.
- The HCMV UL38 protein acts as a key viral regulator, activating the mTOR-KAP1 pathway to upregulate L1 expression.
- This synergistic interaction between HCMV and L1 is crucial for viral replication.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Immune Response Against Viral Pathogens
464
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
464

